| L19IL2 or L19TNF or L19IL2/TNF in Patients With Basal Cell Carcinoma (BCC) (NCT07227350) | Philogen S.p.A. | 2026-06-01 |
| Pembrolizumab Plus Belzutifan With or Without Lenvatinib in Localized Renal Cell Carcinoma (NCT07593040) | Vall d'Hebron Institute of Oncology | 2026-06-01 |
| CM336-SOC for Dynamically High-Risk Multiple Myeloma Study (NCT07648459) | Institute of Hematology & Blood Diseases Hospital, China | 2026-06-01 |
| No Guts No Glory Probiotics (NCT07606014) | University Medical Center Groningen | 2026-06-01 |
| Desloratadine to Prevent Taxane-induced Peripheral Neuropathy in Patients With Breast Cancer (NCT07109817) | Montefiore Medical Center | 2026-06-01 |
| Upadacitinib in Adult Patients With Erosive Mucosal Lichen Planus and Lichen Planopilaris: a Prospective Multicenter Randomized Placebo-controlled Study. (NCT07492251) | Centre Hospitalier Universitaire de Nice | 2026-06-01 |
| 4SCAR-T Therapy Targeting GD2, PSMA and CD276 for Treating Neuroblastoma (NCT04637503) | Shenzhen Geno-Immune Medical Institute | 2026-06-01 |
| SBRT Followed by PD-1 Inhibitor, Bevacizumab and TAS-102 as Third-Line Therapy for Recurrent/Metastatic Colorectal Cancer (NCT07535632) | Shanghai Zhongshan Hospital | 2026-06-01 |
| Study of NM8074 in Patients with Dermatomyositis (DM) (NCT06887738) | NovelMed Therapeutics | 2026-06-01 |
| Study of NM8074 in Patients with Anti-Neutrophil Cytoplasmic Antibody (ANCA)-Associated Vasculitis (AAV) (NCT06226662) | NovelMed Therapeutics | 2026-06-01 |
| Efficacy of a GLP-1/FGF21 Dual Agonist for Treating PCOS (NCT07616037) | Shanghai Zhongshan Hospital | 2026-06-01 |
| Mosunetuzumab and Polatuzumab Vedotin With Split-Dose CHP Chemotherapy for Elderly Patients With Diffuse Large B-Cell Lymphoma (NCT06594939) | Medical College of Wisconsin | 2026-06-01 |
| Safety and Preliminary Efficacy of CTX112 in Adult Participants With Relapsed/Refractory Hematologic Autoimmune Disease (NCT07549698) | CRISPR Therapeutics AG | 2026-06-01 |
| Psilocybin-Assisted Therapy (NCT07332143) | Emory University | 2026-06-01 |
| Letrozole Versus Methotrexate for Management of Undisturbed Ectopic Pregnancy (NCT07624903) | Kafrelsheikh University | 2026-06-01 |
| Evaluation of Postoperative Pain and Bacterial Load After Hyalone or Calcium Hydroxide Medication in Mandibular First Molars (NCT07775456) | Future University in Egypt | 2026-06-01 |
| Becotatug Vedotin Combined With Cetuximab in the Later-line Treatment of Metastatic RAS Wild-type Colorectal Cancer (NCT07490119) | Fudan University | 2026-06-01 |
| Ketamine-Assisted Psychotherapy for Treatment-Resistant Depression (NCT07247006) | University of Rochester | 2026-06-01 |
| CAR-T in Relapsed/Refractory Multiple Myeloma (NCT07689058) | Dr. Zaineb Akram | 2026-06-01 |
| Aripiprazole in Body Focused Repetitive Behaviors (NCT05545891) | University of Chicago | 2026-06-01 |
| Computerized Cognitive Behavioral Therapy-Depression (cCBT-D) for Caregivers of Veterans (NCT07547709) | VA Eastern Colorado Health Care System | 2026-06-01 |
| Proof of Concept Study Evaluating the Efficacy and Safety of ATH-063 Treatment in Patients With Relapsed/Refractory Moderately to Severely Active Ulcerative Colitis (UC) (NCT07513181) | Athos Therapeutics Inc | 2026-06-01 |
| Sintilimab Plus FOLFIRI as Second-line Therapy for Patients With HER2-negative Advanced Gastric Cancer (NCT06365008) | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | 2026-06-01 |
| Trastuzumab Rezetecan and Adebrelimab as Neoadjuvant Therapy for HER2-Positive Muscle-Invasive Bladder Cancer (NCT07624201) | Harbin Medical University | 2026-06-01 |
| DB-3Q for the Treatment of Medically Refractory Crohn's Disease (NCT07625293) | Direct Biologics, LLC | 2026-06-01 |
| Olomorasib + Pembrolizumab KRAS G12C Mutant, PD-L1 TPS 1-49% Locally Advanced or Metastatic NSCLC (NCT07639242) | UNC Lineberger Comprehensive Cancer Center | 2026-06-01 |
| CD45RA-depleted DLI for the Treatment of Refractory/Persistent Viral Infections After Haploidentical Transplantation (NCT07662369) | Ruijin Hospital | 2026-06-01 |
| Sacituzumab Tirumotecan +/- Pembrolizumab in I/O Exposed Metastatic or Recurrent Ovarian Clear Cell Cancer (NCT07718854) | Tufts Medical Center | 2026-06-01 |
| Study to Evaluate the Safety and Efficacy of the GGTA1 KO Thymokidney in Patients With ESRD (NCT07224763) | United Therapeutics | 2026-06-01 |
| A Study to Evaluate ANS014004 in Combination With EGFR-TKI in Non-Small Cell Lung Cancer (NCT07285148) | Beijing Pearl Biotechnology Limited Liability Company | 2026-06-01 |
| Early Phase Study Evaluating MEK and MDM2 Inhibition in Patients With NF1 and MPNST (NCT06735820) | AeRang Kim | 2026-06-01 |
| Confirmatory Trial of Gamma Neurofeedback to Improve Working Memory in Schizophrenia (NCT07592169) | University of California, San Diego | 2026-06-01 |
| Boosting Osimertinib Blood Brain Barrier Penetration (NCT07485452) | Maastricht University Medical Center | 2026-06-01 |
| An Open-label, Phase 2 Pilot Study on the Efficacy and Safety of Piclidenoson in Patients With Lowe Syndrome (NCT07410455) | Can-Fite BioPharma | 2026-06-01 |
| QLS4131 Combination Therapy in Malignant Plasma Cell Neoplasms (NCT07560449) | Qilu Pharmaceutical Co., Ltd. | 2026-06-01 |
| PSMA/CD70 Bi-specific CAR-T Cell Therapy (NCT05437341) | Shenzhen Geno-Immune Medical Institute | 2026-06-01 |
| Combination Upper-Airway Electrical and Pharmacological Stimulation for Obstructive Sleep Apnea (NCT07577661) | Brigham and Women's Hospital | 2026-06-01 |
| Ruxolitinib and Enzalutamide for the Treatment of Metastatic Castration-Resistant Prostate Cancer (NCT06616155) | University of Michigan Rogel Cancer Center | 2026-06-01 |
| Pharmacoscopy for Patients With Refractory Primary Brain Tumors (NCT06804655) | University of Zurich | 2026-06-01 |
| Intervention of CAR-T Against Cervical Cancer (NCT03356795) | Shenzhen Geno-Immune Medical Institute | 2026-06-01 |
| Bosentan in the Treatment of Giant Cell Arteritis (NCT06957002) | Assistance Publique - Hôpitaux de Paris | 2026-06-01 |
| A Dose Ranging Study to Examine TDS-Testosterone 5% (NCT01894308) | Transdermal Delivery Solutions Corp | 2026-06-01 |
| Semaglutide (Wegovy) Treatment for Trichotillomania (NCT07282769) | University of Chicago | 2026-06-01 |
| SARS-CoV-2 and Herpesvirus Inhibition for Ending Long COVID Dysfunction (NCT07597902) | Icahn School of Medicine at Mount Sinai | 2026-06-01 |
| A Phase 2 Study of Luvometinib Combined With Anlotinib in KRAS-mutated NSCLC (NCT07562581) | Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd. | 2026-06-01 |
| Safety and Efficacy Evaluation of 4th Generation Safety-engineered CAR T Cells Targeting Sarcomas (NCT03356782) | Shenzhen Geno-Immune Medical Institute | 2026-06-01 |
| Study of Paclitaxel Polymeric Micelles Combined With HP and Adebelimab Versus Taxane Combined With HP as First-Line Treatment for Advanced HER2-Positive Breast Cancer (NCT07581795) | Fudan University | 2026-06-01 |
| Neoadjuvant HRS-4642 Plus Chemotherapy With or Without Immunotherapy for Pancreatic Cancer (NCT07691593) | Changhai Hospital | 2026-06-01 |
| Effectiveness of Dextrose Pleurodesis for the Management of Post-Operative Air Leak (NCT07548047) | Thomas Jefferson University | 2026-06-01 |
| Multimodal Ablation Combined With Perioperative Tislelizumab and Chemotherapy for Resectable II-IIIB NSCLC (NCT07729670) | Cancer Institute and Hospital, Chinese Academy of Medical Sciences | 2026-06-01 |
| Spatiotemporal Evolution of Traditional Chinese Medicine Mechanisms in Acute Ischemic Stroke Treated With Dengzhan Xixin and Dengzhan Shengmai (NCT07591883) | Guangdong Provincial Hospital of Traditional Chinese Medicine | 2026-06-01 |
| GD2/PSMA Bi-specific CAR-T Cell Therapy (NCT05437315) | Shenzhen Geno-Immune Medical Institute | 2026-06-01 |
| CALM-AF-AI: Counteracting Age-related Loss of Muscle With AAV-Follistatin Combined With Angiogenesis-Inducing VEGF Plasmid Gene Therapy (NCT07443826) | Unlimited Biotechnology LLC | 2026-06-01 |
| Intermittent Hypoxic Training as Neoadjuvant Therapy for Lung Squamous Cell Carcinoma (NCT07618793) | zhang yi | 2026-06-01 |
| Colchicine to Reduce Coronary Artery Inflammation in People With HIV (NCT07704164) | Instituto de Investigación Hospital Universitario La Paz | 2026-06-01 |
| Use of Biocompatible Thermoplastic Impregnated With Vancomycin as a Temporary Orthopedic Spacer (NCT07031999) | Hospital Universitario Evangelico de Curitiba | 2026-06-01 |
| RESET-MS: A Study to Evaluate the Safety and Efficacy of CABA-201 in Participants With Multiple Sclerosis (NCT07006805) | Cabaletta Bio | 2026-06-01 |
| Dapagliflozin Combined With Next-generation Hormonal Agent (NHA) Versus Single NHA in Participants With Metastatic Castrate-resistant Prostate Cancer (NCT07310433) | Yung NA | 2026-06-01 |
| Phase II Trial of Sacituzumab Tirumotecan in Patients With SMARCB1-Deficient Renal Medullary Carcinoma (NCT07438626) | M.D. Anderson Cancer Center | 2026-06-01 |
| Hypofractionated Chemoradiotherapy With Tislelizumab and Surufatinib for Unresectable Stage III NSCLC (NCT07609121) | Sun Yat-sen University | 2026-06-01 |
| Romiplostim N01 in the Treatment of Refractory Chemoradiotherapy-induced AA (NCT07532408) | Peking Union Medical College Hospital | 2026-06-01 |
| Mosunetuzumab in Combination With Pirtobrutinib in Patients With Relapsed or Refractory Waldenstrom Macroglobulinemia (MPOWER) (NCT07548450) | University of Utah | 2026-06-01 |
| Hepatic Arterial Infusion Chemotherapy Plus Envafolimab and Lenvatinib for First-Line Unresectable Advanced Biliary Tract Cancer (NCT07636798) | West China Hospital | 2026-06-01 |
| 68Ga-NYM207 PET/CT Imaging in Hepatocellular Carcinoma (NCT07590336) | Peking Union Medical College Hospital | 2026-06-01 |
| CD19/22 Bi-specific CAR-T Cell Therapy (NCT05432882) | Shenzhen Geno-Immune Medical Institute | 2026-06-01 |
| Zinc as an Adjunctive Therapy for Cervical Dystonia (NCT07140874) | University of Florida | 2026-06-01 |
| Oncolytic Virus (H101) + SBRT + Chemotherapy + Targeted Therapy + Immunotherapy for Unresectable CRLM (NCT07381309) | Jun Huang | 2026-06-01 |
| Study of NM8074 in Soliris-Treated Patients With Paroxysmal Nocturnal Hemoglobinuria (PNH) (NCT05731050) | NovelMed Therapeutics | 2026-06-01 |
| Effect of iNO in Patients With Submassive and Massive PE (NCT04996667) | University of California, Los Angeles | 2026-06-01 |
| Real-world Trial of Individualized Precision Oncology (NCT07346209) | University of California, San Diego | 2026-06-01 |
| CsA+EPAG/HPAG+Romiplostim N01 in the Treatment of Newly-diagnosed SAA/TD-NSAA (NCT07523009) | Peking Union Medical College Hospital | 2026-06-01 |
| Successive Doses of GnRH Agonist Versus Single Dose of GnRH Agonist to Trigger Ovulation in Hyper-responders (NCT07569315) | Bedaya Hospital | 2026-06-01 |
| Antigen-specific T Cells Against Lung Cancer (NCT03356808) | Shenzhen Geno-Immune Medical Institute | 2026-06-01 |
| A Phase 2b Study of SPI-1005 to Prevent Acute Noise Induced Hearing Loss (NCT02779192) | Sound Pharmaceuticals, Incorporated | 2026-06-01 |
| Phase II Trial of Lu-177 FAP-2286 in Patients With Carcinoma of Unknown Primary (NCT07434180) | Peter MacCallum Cancer Centre, Australia | 2026-06-01 |
| Efficacy and Speed of Response of Lebrikizumab in High-Burden Prurigo Nodularis Patients (NCT07620561) | University of Maryland, Baltimore | 2026-06-01 |
| Zanzalintinib for Advanced Urothelial Carcinoma Progressing After Prior Therapy (NCT07185945) | Guru Sonpavde | 2026-06-01 |
| A Phase ll, Interventional, Single-arm Study Evaluating the Efficacy and Safety of Inavolisib Plus Ribociclib and Fulvestrant in Chinese Patients With PIK3CA-mutant, HR-positive, HER2-negative Locally Advanced or Metastatic Breast Cancer. (NCT07618390) | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | 2026-06-01 |
| An Exploratory Study on the Use of Ipalotinib (Tislelizumab) Combined With Sunitinib and Olaparib for Neoadjuvant Therapy in HRD-positive Advanced Ovarian Cancer (NCT07667751) | Bai-Rong Xia | 2026-06-01 |
| Intravenous Iron to Improve Symptoms, Quality of Life and Exercise Capacity in HFpEF With Iron Deficiency (NCT07643818) | Government of Jersey | 2026-06-01 |
| A Study of MRD-Guided Zanubrutinib Plus Sonrotoclax in Treatment-Naïve, High-Risk CLL/SLL Patients (NCT07671378) | The First Affiliated Hospital with Nanjing Medical University | 2026-06-01 |
| FOLFOX8 Versus mFOLFOX6 With Bevacizumab or Cetuximab for First-Line Unresectable Metastatic Colorectal Cancer (Phase II) (NCT07621497) | Sun Yat-sen University | 2026-06-01 |
| Sublingual Buprenorphine Through Telemedicine vs In-Person Care as Usual (NCT05339256) | New York State Psychiatric Institute | 2026-06-01 |
| A Phase II Study of GC101 in NSCLC (NCT07560111) | Shanghai Juncell Therapeutics | 2026-06-01 |
| METabolic MODulation to Enhance Insulin Sensitivity and Mitochondrial Function in Type 1 Diabetes (MetMod-T1D) (NCT07699380) | University of Washington | 2026-06-01 |
| Antigen-specific Cytotoxic T Cells in the Treatment of Opportunistic Infections (NCT03159364) | Shenzhen Geno-Immune Medical Institute | 2026-06-01 |
| 68Ga-PSMA-11 PET-directed Radioligand Therapy in Metastatic Hepatocellular Carcinoma (HCC) (NCT06852820) | Melissa Lumish | 2026-06-01 |
| Targeting CD276 (B7-H3) Positive Solid Tumors by 4SCAR-276 (NCT04432649) | Shenzhen Geno-Immune Medical Institute | 2026-06-01 |
| CAR-T Cells Targeting Autoimmune Diseases (NCT05459870) | Shenzhen Geno-Immune Medical Institute | 2026-06-01 |
| Olorofim in Early Coccidioidal Meningitis (NCT07385638) | Fariba Donovan | 2026-06-01 |
| Phase 2a Study of the Efficacy and Safety of TRX-100 in a Human Influenza A Challenge Model (NCT07503405) | Traws Pharma, Inc. | 2026-06-01 |
| FAP PET/CT for Staging Patients With Breast Cancer (NCT07523607) | Odense University Hospital | 2026-06-01 |
| Group Retreat Psilocybin Therapy for Healthcare Clinicians With Loss of Meaning in Their Work and Symptoms of Depression (NCT07565909) | University of Washington | 2026-06-01 |
| Perioperative Ursodeoxycholic Acid for Renal Protection in Adults Undergoing Partial Nephrectomy for Renal Tumors (NCT07672860) | Jinling Hospital, China | 2026-06-01 |
| Topical Phenytoin for Management of Gingival Recession (NCT07590375) | Cairo University | 2026-06-01 |
| THC Versus THC/CBD Versus Placebo to Improve Sleep Quality for Patients With Solid Organ Cancer and Insomnia (NCT07565974) | Mayo Clinic | 2026-06-01 |
| Topical Insulin for Glaucoma (TING2) (NCT07619482) | Stanford University | 2026-06-01 |
| Neoadjuvant Radiotherapy Combined With NALIRIFOX and Adebrelimab in pMMR/MSS Locally Advanced Rectal Cancer: A Prospective, Randomized, Phase II Clinical Trial (NCT07622771) | Sun Yat-sen University | 2026-06-01 |
| HER2 FPBMC in Patients With Metastatic Breast and Prostate Cancer (AM006) (NCT07441889) | University of Virginia | 2026-06-01 |
| A Study of DXC006 With Immune Checkpoint Inhibitors or Platinum for Small Cell Lung Cancer. (NCT07559929) | Hangzhou DAC Biotechnology Co., Ltd. | 2026-06-01 |